Zhonghua Nei Ke Za Zhi. 2025 Feb 1;64(2):110-118. doi: 10.3760/cma.j.cn112138-20240621-00396.
This study aims to improve the quality of clinical treatment and nursing care to standardize perioperative management for patients with liver tumors undergoing co-ablation system therapy. The Committee of Ablation Therapy in Oncology, China Anti-Cancer Association; the Expert Committee on Ablation Therapy; Chinese Society of Clinical Oncology (CSCO); and the Committee of Interventional, Perioperative, and Interventional Physician Branch of Chinese Medical Doctors Association organized medical and nursing experts in China. Based on the clinical practice of co-ablation system therapy in China and relevant domestic literature, an expert consensus about perioperative management was developed. The expert consensus included the key points of perioperative management, prevention, and care of complications; discharge guidance; and follow-up management for patients undergoing co-ablation system therapy of liver tumors. The consensus on the perioperative management of co-ablation system therapy for liver tumors has finally been formulated, serving as a reference and application for medical personnel in relevant fields based on hospital and patient conditions in clinical work.
本研究旨在提高临床治疗和护理质量，规范接受联合消融系统治疗的肝肿瘤患者的围手术期管理。中国抗癌协会肿瘤消融治疗专业委员会、消融治疗专家委员会、中国临床肿瘤学会（CSCO）以及中国医师协会介入医师分会围手术期介入专业委员会组织了国内医学和护理专家。基于中国联合消融系统治疗的临床实践及国内相关文献，制定了关于围手术期管理的专家共识。该专家共识涵盖了肝肿瘤联合消融系统治疗患者围手术期管理的要点、并发症的预防与护理、出院指导以及随访管理。最终形成了肝肿瘤联合消融系统治疗围手术期管理的共识，供临床工作中相关领域的医务人员根据医院和患者情况参考应用。
